Living with an autoimmune disease often means navigating a lifelong, complex condition. A recent study estimates that ...

Please provide your email address to receive an email when new articles are posted on . A “complete eradication” of B cells with chimeric antigen receptor T-cell therapy is responsible for the ...

Novel therapies for certain autoimmune diseases have been developed to end B cell-driven immune attacks on normal tissues.

In vivo CD19 CAR T-cell therapy showed promising results in a feasibility study of five patients with refractory systemic ...

Researchers at the First Affiliated Hospital of the University of Science and Technology of China claim that an in vivo CD8 T ...

Tr1X has won an FDA green light for a clinical trial testing TRX319, a cell therapy designed to restore immune balance, for ...

Kernal has been awarded up to $48M funding to accelerate the development of KR-402, a next-generation in vivo CAR T-cell ...

CD19-targeting UB-VV11 became the first in vivo CAR-T cell therapy to be cleared for human testing by the FDA last year, and ...

The stars have aligned for Bristol Myers Squibb and Orbital Therapeutics. | The stars have aligned for Bristol Myers Squibb ...